Hypophosphatasia refers to a rare metabolic disorder characterized by deficient serum alkaline phosphatase activity. The effects of hypophosphatasia are primarily seen in the skeletal system. The condition has marked variation in clinical expression (see subtypes).
The true incidence is uncertain as it is thought many people may live with mild forms of the disease without being diagnosed. Some authors have estimated its prevalence at 1 in 100,000. It can display either autosomal dominant or recessive inheritance, which complicates genetic counseling.
Complications are primarily those of hypercalcemia.
The underlying genetic abnormality is almost exclusively due to a mutation in the ALPL gene that encodes for tissue non-specific alkaline phosphatase (TNSAP) enzyme. This results in defective bone mineralization and extracellular accumulation of TNSAP substrates. With over 300 different specific mutations recognized, the severity of the resultant clinical disorder depends on the degree to which TNSAP activity is impaired. The severer the impairment, the earlier the presentation.
Hypophosphatasia can be divided into several groups (at least six types 6,8) according to age at presentation 3,6
- perinatal lethal hypophosphatasia: uniformly lethal 3
- perinatal benign hypophosphatasia: variable severity
- infantile hypophosphatasia: lethal in ~50% of cases 3
- childhood hypophosphatasia
- adult hypophosphatasia: relatively mild
Some of the skeletal features are common across subtypes and include 4:
- 1. Sergi C, Mornet E, Troeger J et-al. Perinatal hypophosphatasia: radiology, pathology and molecular biology studies in a family harboring a splicing mutation (648+1A) and a novel missense mutation (N400S) in the tissue-nonspecific alkaline phosphatase (TNSALP) gene. Am. J. Med. Genet. 2001;103 (3): 235-40. Am. J. Med. Genet. (link) - Pubmed citation
- 2. Henthorn PS, Whyte MP. Infantile hypophosphatasia: successful prenatal assessment by testing for tissue-non-specific alkaline phosphatase isoenzyme gene mutations. Prenat. Diagn. 1995;15 (11): 1001-6. - Pubmed citation
- 3. Shohat M, Rimoin DL, Gruber HE et-al. Perinatal lethal hypophosphatasia; clinical, radiologic and morphologic findings. Pediatr Radiol. 1991;21 (6): 421-7. - Pubmed citation
- 4. Kozlowski K, Sutcliffe J, Barylak A et-al. Hypophosphatasia. Review of 24 cases. Pediatr Radiol. 1976;5 (2): 103-17. - Pubmed citation
- 5. Sinico M, Levaillant JM, Vergnaud A et-al. Specific osseous spurs in a lethal form of hypophosphatasia correlated with 3D prenatal ultrasonographic images. Prenat. Diagn. 2007;27 (3): 222-7. doi:10.1002/pd.1648 - Pubmed citation
- 6. Mornet E. Hypophosphatasia. Orphanet J Rare Dis. 2007;2 : 40. doi:10.1186/1750-1172-2-40 - Free text at pubmed - Pubmed citation
- 7. Kritsaneepaiboon S, Jaruratanasirikul S, Dissaneevate S. Clinics in diagnostic imaging (112). Perinatal lethal hypophosphatasia (PLH). Singapore Med J. 2006;47 (11): 987-92. Singapore Med J (link) - Pubmed citation
- 8. Daldrup-Link HE, Gooding CA. Essentials of Pediatric Radiology, A Multimodality Approach. Cambridge Univ Pr. (2010) ISBN:0521515211. Read it at Google Books - Find it at Amazon
- 9. Schumacher R, Seaver LH, Spranger J. Fetal Radiology, A Diagnostic Atlas. Springer Verlag. (2011) ISBN:3642035590. Read it at Google Books - Find it at Amazon
- 10 . Connie Y. Chang, DI. Rosenthal, DM, et al. Huang. Imaging Findings of Metabolic Bone Disease. (2016) RadioGraphics. 36 (6): 1871-1887. doi:10.1148/rg.2016160004 - Pubmed